General Biologics, Inc
General Biologics, Inc., based in Cambridge, MA, leverages the principles of synthetic biology and protein engineering to develop innovative therapeutics aimed at addressing unmet medical needs. The company focuses on creating groundbreaking fusion protein therapeutics, particularly for the treatment of hypoxia, by employing rational biological design and advanced protein modeling techniques.
With a team of skilled synthetic biologists, General Biologics integrates protein design with cell biology and signal transduction physiology to pioneer novel therapeutic solutions. Their approach emphasizes the potential of rationally designed biological systems to transform the landscape of medical treatments that have been historically overlooked by the research community and investors.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

